Market Dynamics and Drivers of the Adhesion Barrier Industry

The adhesion barriers market is valued at an estimated USD 529 million in 2020 and is projected to reach USD 769 million by 2025, at a CAGR of 7.8% (2020 – 2025). The report studies the market scenario and its growth prospects during the forecast period. In addition, the report includes a detailed analysis of the leading competitors functioning in this market. In order to calculate the market size, the report considers the sales, value, volume, and exclude new installations, replacement, spares, shipments, aftermarket sales, retrofit, and services market.

The market research report on the Adhesion Barrier industry analyzes the overall estimates of all the segments and sub-segments of the market, on a global and regional scale. The report presents the historical data for the time period 2018-2020, revenue estimates from 2015-2020, and forecasts from 2020 till 2025. The report presents a detailed analysis of the market trends, market dynamics, leading competitors, technological innovations and inventions, key developments, lucrative opportunities, and future strategies. The market size is calculated on the basis of the financials generated through sales from the mentioned segments and sub-segments in this research study. The overall market has been analyzed using the top-down and bottom-up approaches for data validation and accuracy measures.

Browse 171 market data Tables and 38 Figures spread through 203 Pages and in-depth TOC on adhesion barrier market Request sample report:

The increasing volume of surgeries and sports-related injuries, rising geriatric population, and the increasing awareness about adhesion formation and adhesion-related diseases are the major factors driving the growth of this market. On the other hand, the reluctance towards the usage of adhesion barriers amongst surgeons is expected to restrain the growth of this market during the forecast period. However, currently, due to the COVID-19 pandemic, this market is witnessing a slight dip in its growth rate as a result of the decrease in the number of surgical procedures performed to safeguard patients. The dip in surgical interventions is uneven, as different countries were affected by the virus at different points of time in the year. This has resulted in variations in the normal operation of healthcare facilities, such as hospitals and surgical centers. The normalization of the global economy will slowly increase the surgical procedures kept on hold. This will, in turn, lead to a growth in the demand for biosurgery products such as adhesion barrier products from the last quarter of 2020 across North America and Europe, and from the first quarter of 2021 across the rest of the world

The research report categorizes the adhesion barrier market into the following segments and subsegments:

By Type

  • Synthetic Adhesion Barriers
    • Hyaluronic Acid
    • Regenerated Cellulose
    • Polyethylene Glycol
    • Other Synthetic Adhesion Barrers
  • Natural Adhesion Barriers
    • Collagen & Protein
    • Fibrin

By Delivery Mode

  • Film Formulations
  • Gel Formulations
  • Liquid Formulations      

By Application

  • Gynecological Surgeries
  • General/Abdominal Surgeries
  • Orthopedic Surgeries
  • Cardiovascular Surgeries
  • Neurological Surgeries
  • Urological Surgeries
  • Reconstructive Surgeries
  • Other Surgeries**
  • **Other surgeries include ear, nose, throat, and burn surgeries

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East
  • Africa

The Global Adhesion Barrier Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. The report also analyzes the development proposals and the feasibility of new investments. This report has been collated in order to provide guidance and direction to the companies and individuals interested in buying this research report.

Johnson & Johnson (US), Baxter International (US), Becton, Dickinson, and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), WL Gore & Associates (US), Allosource (US) (Total 15 companies and 5 other companies undergoing clinical trials)

Frequently Asked Questions (FAQ):

Q.1 What are the products considered out of scope for this study?

Ans. The study excludes the use of other procedures and products for preventing adhesions, such as surgical procedures, antiadhesive agents, drugs, and physical therapies.Additionally, the study also excludes the market for products that have not been approved for adhesion prevention and are used off-label.

Q.2 How was the final market size arrived at for the adhesion barrier market?

The total size of the adhesion barrier market was arrived at after data triangulation from different approaches, including revenue share analysis, demand side analysis, and through secondary research. After the completion of each approach, the weighted average of the three approaches was taken on the basis of the level of assumptions used in each approach.

Q.3 What were some of the companies that were approached to validate the study?

To validate our final data findings and assumptions considered for the study, we approached primaries from both supply and demand side of this market. Some of the top companies approached from the supply side included W.L Gore & Associates, Sanofi Genzyme, Biom’up, amongst others. On demand side, various surgeons across different surgical areas were approached to understand the market dynamics. Additionally, independent consultants were also approached to validate the final market numbers.

Q.4 Name some of the industry trends affecting the adhesion barrier market?

With the increasing number of minimally invasive surgeries, there is a growing demand for advanced biosurgical products. Minimally invasive surgeries, such as laparoscopic procedures, have been associated with minimum adhesions. The traditional forms of adhesion barriers, such as films, are not suitable for such surgeries, as they require larger incisions in order to be inserted. Hence, adhesion barrier gels are being researched for laparoscopic surgeries.

Q.5 How is COVID-19 affectingthe dynamics of the adhesion barrier market?

Medical products such as adhesion barriers, which are considered as a part of the biosurgery field, are expected to show a small decline in revenues in the years 2020 and 2021 due to the pandemic. Additionally, the lockdown measures imposed globally have disrupted the supply of raw materials in order to manufacture these products. Another factor that has impacted on the market is the slight delay in clinical trials assessments, which could further delay the launch of newer products in the market.

However, these factors have impacted the market only on a short-term basis. Post the COVID-19 scenario, awareness on the use of adhesion barrier products to avoid adhesion-related complications (such as infertility) will continue to aid in the increase in the adoption of such products during the forecast period.

Content Source:—exclusive-report-by-marketsandmarkets-301143783.html